$171.56
Currently 42 wall-street analysts regularly analyze the financials of Biogen Inc. on a frequent basis to provide recommendations along with target share price. 42 analysts offering 12-month price forecasts for Biogen Inc. (BIIB) have a share price target of $190.93. This median of share price forecast represents a 11.29% upside from the latest price of $171.56 as on 25.01.26.
As per the chart shown above, analysts believe that the Biogen Inc. (BIIB) share price will touch around $190.93 in next 12-months.
Below is a chart showing the percentage difference between Biogen Inc.'s share price and its median forecast price. As on 25.01.26, the difference is -2.36%
Based on 42 analysts tracking and researching Biogen Inc. (BIIB) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 22 | 20 | 20 |
| Outperform | 10 | 10 | 10 |
| Hold | 10 | 12 | 12 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |